Skip to content
SEC filings edition: Wednesday, November 18, 2026 · 275 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Friday, November 20, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 18, 2026 0bankruptcies 5delisting notices 2late filings 33leadership changes 0IPO filings 177private raises 25earnings releases
Company page · CIK 1396814 · PCRX

Pacira BioSciences, Inc.

Filing with the SEC — delisting notice SEC-reporting company Brisbane, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Debt accelerated or in defaultOn Nov 17, 2026 the company reported an event that accelerates or increases a direct financial obligation (Item 2.04), for example a default under a loan or bond agreement.
  • Exchange listing at riskOn Nov 17, 2026 the company disclosed a notice from its exchange (Item 3.01): Nasdaq. Exchanges usually give a period to regain compliance before delisting.
  • Securities removed from an exchangeA Form 25-NSE filed on Nov 17, 2026 removes a class of the company’s securities from listing (Removed from Nasdaq Stock Market). It can concern shares, warrants, notes or units — check the form for the class.
  • Change in controlOn Nov 17, 2026 the company reported a change in control (Item 5.01).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$726M$701M
Net income (loss)$7M−$99.6M
Total assets$1.26B$1.55B
Total liabilities$572M$775M
Stockholders’ equity$693M$778M
Cash and equivalents$159M$277M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Pacira BioSciences, Inc.
Formerly: Pacira Pharmaceuticals, Inc.
CIK
0001396814
Tickers
PCRX
Kind of filer
SEC-reporting company
Large accelerated filer
Status
Filing with the SEC — delisting notice
State of incorporation
Delaware
Business address
Brisbane, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 17, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Director or officer change: Director or officer change
    Form 8-K · items 1.01, 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Nov 17, 2026 · filing · edition of Nov 17, 2026
  • Change in control
    Form 8-K · items 1.01, 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Nov 17, 2026 · filing · edition of Nov 17, 2026
  • Notice from the exchange: Nasdaq
    Form 8-K · items 1.01, 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Nov 17, 2026 · filing · edition of Nov 17, 2026
  • Debt accelerated or in default
    Form 8-K · items 1.01, 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Nov 17, 2026 · filing · edition of Nov 17, 2026
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Nov 17, 2026 · filing · edition of Nov 17, 2026
  • Delisted by the exchange (Form 25-NSE): Removed from Nasdaq Stock Market
    Form 25-NSE · filed Nov 17, 2026 · filing · edition of Nov 17, 2026
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 5, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 4, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 4, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 8.01, 9.01 · filed Jun 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Apr 30, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed Apr 30, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 26, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Feb 26, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 28, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 8, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Aug 8, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 5, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 5, 2025 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 7.01, 9.01 · filed Jul 10, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 8, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 27, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Feb 27, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 30, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 21, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 10, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 9.01 · filed Nov 6, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 9.01 · filed Nov 6, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 6, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 21, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 27, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jul 30, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Jul 30, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07 · filed Jun 13, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed May 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 7, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 7.01, 9.01 · filed Feb 29, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 7.01, 9.01 · filed Feb 29, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Feb 29, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 4, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Dec 21, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 2, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 2, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 10, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Sep 26, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 2, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 2, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 20, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 3, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 3, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01 · filed Mar 22, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 28, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Feb 28, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 5, 2023 · filing